A?medication?(also referred to as?medicine,?pharmaceutical drug, or simply?drug) is a?drug?used to?diagnose,?cure,?treat, or?prevent?disease.?Drug therapy (pharmacotherapy) is an important part of the?medical field?and relies on the science of?pharmacology?for continual advancement and on?pharmacy?for appropriate management.
This report aims to provide a comprehensive presentation of the global market for Brand Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brand Drugs. This report contains market size and forecasts of Brand Drugs in global, including the following market information:
Global Brand Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Brand Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Brand Drugs companies in 2022 (%)
The global Brand Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Biopharmaceutical Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Brand Drugs include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Brand Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brand Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Brand Drugs Market Segment Percentages, by Type, 2022 (%)
Biopharmaceutical
Chemistry Medicine
Global Brand Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Brand Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Brand Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Brand Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brand Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Brand Drugs revenues share in global market, 2022 (%)
Key companies Brand Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Brand Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Brand Drugs, market overview.
Chapter 2: Global Brand Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Brand Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Brand Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Brand Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Brand Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brand Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Brand Drugs Overall Market Size
2.1 Global Brand Drugs Market Size: 2022 VS 2029
2.2 Global Brand Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Brand Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Brand Drugs Players in Global Market
3.2 Top Global Brand Drugs Companies Ranked by Revenue
3.3 Global Brand Drugs Revenue by Companies
3.4 Global Brand Drugs Sales by Companies
3.5 Global Brand Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Brand Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Brand Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Brand Drugs Players in Global Market
3.8.1 List of Global Tier 1 Brand Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Brand Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Brand Drugs Market Size Markets, 2022 & 2029
4.1.2 Biopharmaceutical
4.1.3 Chemistry Medicine
4.2 By Type - Global Brand Drugs Revenue & Forecasts
4.2.1 By Type - Global Brand Drugs Revenue, 2018-2023
4.2.2 By Type - Global Brand Drugs Revenue, 2024-2029
4.2.3 By Type - Global Brand Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Brand Drugs Sales & Forecasts
4.3.1 By Type - Global Brand Drugs Sales, 2018-2023
4.3.2 By Type - Global Brand Drugs Sales, 2024-2029
4.3.3 By Type - Global Brand Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Brand Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Brand Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Brand Drugs Revenue & Forecasts
5.2.1 By Application - Global Brand Drugs Revenue, 2018-2023
5.2.2 By Application - Global Brand Drugs Revenue, 2024-2029
5.2.3 By Application - Global Brand Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Brand Drugs Sales & Forecasts
5.3.1 By Application - Global Brand Drugs Sales, 2018-2023
5.3.2 By Application - Global Brand Drugs Sales, 2024-2029
5.3.3 By Application - Global Brand Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Brand Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Brand Drugs Market Size, 2022 & 2029
6.2 By Region - Global Brand Drugs Revenue & Forecasts
6.2.1 By Region - Global Brand Drugs Revenue, 2018-2023
6.2.2 By Region - Global Brand Drugs Revenue, 2024-2029
6.2.3 By Region - Global Brand Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Brand Drugs Sales & Forecasts
6.3.1 By Region - Global Brand Drugs Sales, 2018-2023
6.3.2 By Region - Global Brand Drugs Sales, 2024-2029
6.3.3 By Region - Global Brand Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Brand Drugs Revenue, 2018-2029
6.4.2 By Country - North America Brand Drugs Sales, 2018-2029
6.4.3 US Brand Drugs Market Size, 2018-2029
6.4.4 Canada Brand Drugs Market Size, 2018-2029
6.4.5 Mexico Brand Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Brand Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Brand Drugs Sales, 2018-2029
6.5.3 Germany Brand Drugs Market Size, 2018-2029
6.5.4 France Brand Drugs Market Size, 2018-2029
6.5.5 U.K. Brand Drugs Market Size, 2018-2029
6.5.6 Italy Brand Drugs Market Size, 2018-2029
6.5.7 Russia Brand Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Brand Drugs Market Size, 2018-2029
6.5.9 Benelux Brand Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Brand Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Brand Drugs Sales, 2018-2029
6.6.3 China Brand Drugs Market Size, 2018-2029
6.6.4 Japan Brand Drugs Market Size, 2018-2029
6.6.5 South Korea Brand Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Brand Drugs Market Size, 2018-2029
6.6.7 India Brand Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Brand Drugs Revenue, 2018-2029
6.7.2 By Country - South America Brand Drugs Sales, 2018-2029
6.7.3 Brazil Brand Drugs Market Size, 2018-2029
6.7.4 Argentina Brand Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Brand Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Brand Drugs Sales, 2018-2029
6.8.3 Turkey Brand Drugs Market Size, 2018-2029
6.8.4 Israel Brand Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Brand Drugs Market Size, 2018-2029
6.8.6 UAE Brand Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Brand Drugs Major Product Offerings
7.1.4 Pfizer Brand Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Brand Drugs Major Product Offerings
7.2.4 Roche Brand Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Brand Drugs Major Product Offerings
7.3.4 Sanofi Brand Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Brand Drugs Major Product Offerings
7.4.4 Johnson & Johnson Brand Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Company Summary
7.5.2 Merck & Co. (MSD) Business Overview
7.5.3 Merck & Co. (MSD) Brand Drugs Major Product Offerings
7.5.4 Merck & Co. (MSD) Brand Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck & Co. (MSD) Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Brand Drugs Major Product Offerings
7.6.4 Novartis Brand Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Brand Drugs Major Product Offerings
7.7.4 AbbVie Brand Drugs Sales and Revenue in Global (2018-2023)
7.7.5 AbbVie Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Brand Drugs Major Product Offerings
7.8.4 Gilead Sciences Brand Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Gilead Sciences Key News & Latest Developments
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Company Summary
7.9.2 GlaxoSmithKline (GSK) Business Overview
7.9.3 GlaxoSmithKline (GSK) Brand Drugs Major Product Offerings
7.9.4 GlaxoSmithKline (GSK) Brand Drugs Sales and Revenue in Global (2018-2023)
7.9.5 GlaxoSmithKline (GSK) Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Brand Drugs Major Product Offerings
7.10.4 Amgen Brand Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Amgen Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Brand Drugs Business Overview
7.11.3 AstraZeneca Brand Drugs Major Product Offerings
7.11.4 AstraZeneca Brand Drugs Sales and Revenue in Global (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Company Summary
7.12.2 Bristol-Myers Squibb Brand Drugs Business Overview
7.12.3 Bristol-Myers Squibb Brand Drugs Major Product Offerings
7.12.4 Bristol-Myers Squibb Brand Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Bristol-Myers Squibb Key News & Latest Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Company Summary
7.13.2 Eli Lilly Brand Drugs Business Overview
7.13.3 Eli Lilly Brand Drugs Major Product Offerings
7.13.4 Eli Lilly Brand Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Eli Lilly Key News & Latest Developments
7.14 Teva
7.14.1 Teva Company Summary
7.14.2 Teva Business Overview
7.14.3 Teva Brand Drugs Major Product Offerings
7.14.4 Teva Brand Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Teva Key News & Latest Developments
7.15 Bayer
7.15.1 Bayer Company Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Brand Drugs Major Product Offerings
7.15.4 Bayer Brand Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Bayer Key News & Latest Developments
7.16 Novo Nordisk
7.16.1 Novo Nordisk Company Summary
7.16.2 Novo Nordisk Business Overview
7.16.3 Novo Nordisk Brand Drugs Major Product Offerings
7.16.4 Novo Nordisk Brand Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Novo Nordisk Key News & Latest Developments
7.17 Allergan
7.17.1 Allergan Company Summary
7.17.2 Allergan Business Overview
7.17.3 Allergan Brand Drugs Major Product Offerings
7.17.4 Allergan Brand Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Allergan Key News & Latest Developments
7.18 Takeda
7.18.1 Takeda Company Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Brand Drugs Major Product Offerings
7.18.4 Takeda Brand Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Takeda Key News & Latest Developments
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Company Summary
7.19.2 Boehringer Ingelheim Business Overview
7.19.3 Boehringer Ingelheim Brand Drugs Major Product Offerings
7.19.4 Boehringer Ingelheim Brand Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Boehringer Ingelheim Key News & Latest Developments
7.20 Takeda
7.20.1 Takeda Company Summary
7.20.2 Takeda Business Overview
7.20.3 Takeda Brand Drugs Major Product Offerings
7.20.4 Takeda Brand Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Takeda Key News & Latest Developments
8 Global Brand Drugs Production Capacity, Analysis
8.1 Global Brand Drugs Production Capacity, 2018-2029
8.2 Brand Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Brand Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Brand Drugs Supply Chain Analysis
10.1 Brand Drugs Industry Value Chain
10.2 Brand Drugs Upstream Market
10.3 Brand Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Brand Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Brand Drugs in Global Market
Table 2. Top Brand Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Brand Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Brand Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Brand Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Brand Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Brand Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Brand Drugs Product Type
Table 9. List of Global Tier 1 Brand Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brand Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Brand Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Brand Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Brand Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Brand Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Brand Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Brand Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Brand Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Brand Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Brand Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Brand Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Brand Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Brand Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Brand Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Brand Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Brand Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Brand Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Brand Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Brand Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Brand Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Brand Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Brand Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Brand Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Brand Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Brand Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Brand Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Brand Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Brand Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Brand Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Brand Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Brand Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Brand Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Brand Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Brand Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Brand Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Brand Drugs Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Brand Drugs Product Offerings
Table 48. Pfizer Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Brand Drugs Product Offerings
Table 52. Roche Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Brand Drugs Product Offerings
Table 56. Sanofi Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Brand Drugs Product Offerings
Table 60. Johnson & Johnson Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Merck & Co. (MSD) Company Summary
Table 63. Merck & Co. (MSD) Brand Drugs Product Offerings
Table 64. Merck & Co. (MSD) Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Merck & Co. (MSD) Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Brand Drugs Product Offerings
Table 68. Novartis Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. AbbVie Company Summary
Table 71. AbbVie Brand Drugs Product Offerings
Table 72. AbbVie Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. AbbVie Key News & Latest Developments
Table 74. Gilead Sciences Company Summary
Table 75. Gilead Sciences Brand Drugs Product Offerings
Table 76. Gilead Sciences Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Gilead Sciences Key News & Latest Developments
Table 78. GlaxoSmithKline (GSK) Company Summary
Table 79. GlaxoSmithKline (GSK) Brand Drugs Product Offerings
Table 80. GlaxoSmithKline (GSK) Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. GlaxoSmithKline (GSK) Key News & Latest Developments
Table 82. Amgen Company Summary
Table 83. Amgen Brand Drugs Product Offerings
Table 84. Amgen Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Amgen Key News & Latest Developments
Table 86. AstraZeneca Company Summary
Table 87. AstraZeneca Brand Drugs Product Offerings
Table 88. AstraZeneca Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. AstraZeneca Key News & Latest Developments
Table 90. Bristol-Myers Squibb Company Summary
Table 91. Bristol-Myers Squibb Brand Drugs Product Offerings
Table 92. Bristol-Myers Squibb Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Bristol-Myers Squibb Key News & Latest Developments
Table 94. Eli Lilly Company Summary
Table 95. Eli Lilly Brand Drugs Product Offerings
Table 96. Eli Lilly Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Eli Lilly Key News & Latest Developments
Table 98. Teva Company Summary
Table 99. Teva Brand Drugs Product Offerings
Table 100. Teva Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Teva Key News & Latest Developments
Table 102. Bayer Company Summary
Table 103. Bayer Brand Drugs Product Offerings
Table 104. Bayer Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Bayer Key News & Latest Developments
Table 106. Novo Nordisk Company Summary
Table 107. Novo Nordisk Brand Drugs Product Offerings
Table 108. Novo Nordisk Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Novo Nordisk Key News & Latest Developments
Table 110. Allergan Company Summary
Table 111. Allergan Brand Drugs Product Offerings
Table 112. Allergan Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. Allergan Key News & Latest Developments
Table 114. Takeda Company Summary
Table 115. Takeda Brand Drugs Product Offerings
Table 116. Takeda Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Takeda Key News & Latest Developments
Table 118. Boehringer Ingelheim Company Summary
Table 119. Boehringer Ingelheim Brand Drugs Product Offerings
Table 120. Boehringer Ingelheim Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. Boehringer Ingelheim Key News & Latest Developments
Table 122. Takeda Company Summary
Table 123. Takeda Brand Drugs Product Offerings
Table 124. Takeda Brand Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. Takeda Key News & Latest Developments
Table 126. Brand Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Brand Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Brand Drugs Production by Region, 2018-2023 (K Units)
Table 129. Global Brand Drugs Production by Region, 2024-2029 (K Units)
Table 130. Brand Drugs Market Opportunities & Trends in Global Market
Table 131. Brand Drugs Market Drivers in Global Market
Table 132. Brand Drugs Market Restraints in Global Market
Table 133. Brand Drugs Raw Materials
Table 134. Brand Drugs Raw Materials Suppliers in Global Market
Table 135. Typical Brand Drugs Downstream
Table 136. Brand Drugs Downstream Clients in Global Market
Table 137. Brand Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Brand Drugs Segment by Type in 2022
Figure 2. Brand Drugs Segment by Application in 2022
Figure 3. Global Brand Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Brand Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Brand Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Brand Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Brand Drugs Revenue in 2022
Figure 9. By Type - Global Brand Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Brand Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Brand Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Brand Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Brand Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Brand Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Brand Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Brand Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Brand Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Brand Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Brand Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Brand Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Brand Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Brand Drugs Sales Market Share, 2018-2029
Figure 23. US Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Brand Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Brand Drugs Sales Market Share, 2018-2029
Figure 28. Germany Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Brand Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Brand Drugs Sales Market Share, 2018-2029
Figure 37. China Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Brand Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Brand Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Brand Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Brand Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Brand Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Brand Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Brand Drugs by Region, 2022 VS 2029
Figure 54. Brand Drugs Industry Value Chain
Figure 55. Marketing Channels
